The Fellows Research Award is presented annually to fellows within the Department of Medicine who have presented outstanding research.
Researchers from the Sackler Center at WCMC have designed a new class of drugs that targets a master regulatory protein responsible for causing the most common type of non-Hodgkin's lymphoma. Findings published April 14 in Cancer Cell show that an experimental compound designed by the researchers may effectively block the cancer-causing actions of the protein known as BCL6 by attaching to a critical "hot spot" on its surface, thus killing the cancer cells.
Leading hematologists in the Department of Medicine presented new basic and clinical research findings at the 51st Annual Meeting of the American Society of Hematology (ASH) in New Orleans, Dec. 5-8.
Dr. Guzman is widely regarded as a pioneer and expert in devising therapies that target leukemia stem cells. Her research has pioneered the new field of cancer stem cell targeted therapy. To complement her basic laboratory research, she will closely collaborate with our clinical faculty on novel therapies to target leukemia stem cells.
This award is presented annually to members of the Department of Medicine below the rank of professor who perform on outstanding levels in the areas of clinical and/or basic biomedical research. The award has been generously supported by the Michael Wolk Foundation.
Initiated in 2002, this award is presented annually to fellows within the Department of Medicine who have presented outstanding research.
Dr. Peter Martin will be joining the faculty in the Division of Hematology/Oncology as Assistant Professor of Medicine on May 1, 2009. He will be seeing patients at the Center for Lymphoma and Myeloma and will be working with Drs. Eric Feldman, John Leonard, and other faculty in the area of hematological malignancies.
Adding potent research firepower and fresh physical perspectives to combat cancer, the National Cancer Institute (NCI) has funded the new Center on the Microenvironment and Metastasis, which will be headquartered at Cornell University. It is one of 12 new research centers across the nation recently announced by the NCI. This grant is for $13 million over five years.
Physicians from The Jay Monahan Center for Gastrointestinal Health at NewYork-Presbyterian/Weill Cornell Medical Center will reveal the most-up-to-date information on colorectal cancer screening guidelines, risk factors, and risk reduction. In addition, Katie Couric will be on hand to answer questions regarding colorectal cancer and the importance of screening, early detection, and prevention.
The awards are intended to give recipients the freedom and flexibility to explore fundamental scientific questions, to apply the resulting knowledge at the bedside, and to bring insights from the clinical setting back to the laboratory for further exploration.
